ReiThera
Rome, IT
No confirmed program data — ClinicalTrials.gov verification pending
· Last scored 2026-09-07
71.1
Signal Score
○ FDA Inspections
✓ Clinical Trials (1)
○ SEC Filings
○ Press
✓ EMA GMP (4)
○ MHRA GMP
Quick Facts: ReiThera
- Signal Score
- 71.1/100 (as of 2026-09-07)
- Quality Compliance
- 100.0/100
- Headquarters
- Rome, IT
- Modalities
- Adenoviral, AAV
- Active Programs
- Data pending
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About ReiThera
Italian viral vector CDMO. COVID vaccine development.
Signal Score & Pillar Breakdown
Scores are being republished.
Scores are being republished under methodology v3.3. The score shown is the last complete v3.2 result, which is also what directory listings and search results show. A pillar breakdown is not shown because the current one is computed under v3.3 and would not explain a v3.2 score. Regulatory evidence below is current.
Quality Compliance
100.0
FDA InspectionsNo US records on file
EMA GMP Certificates4 on record
Operations
50.0
Programs
— no verified data
Sponsors— no verified data
ModalitiesAdenoviral, AAV
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Source: ClinicalTrials.gov · Retrieved Oct 07, 2026
Financial Stability
60.0
Profile-based financial assessment
SEC FilingsPrivate company
Capacity
58.0
Profile-based capacity assessment
ReiThera EMA GMP Compliance 4 certificates
2024-11
2024-11
2022-01
2022-01
Compliant
Non-Compliant
| Certificate | Site | Country | Inspection Date | Status |
|---|---|---|---|---|
| IT/44/H/2025 | Reithera S.r.l. | Italy | 2024-11-22 | COMPLIANT |
| IT-API/32/H/2025 | Reithera S.r.l. | Italy | 2024-11-22 | COMPLIANT |
| IT-API/119/H/2022 | Reithera S.r.l. | Italy | 2022-01-28 | COMPLIANT |
| IT-API/251/H/2022 | Reithera S.r.l. | Italy | 2022-01-28 | COMPLIANT |
Source: EMA EudraGMDP · Retrieved Oct 07, 2026
Clinical Activity 1 studies
Source: ClinicalTrials.gov · Retrieved Oct 07, 2026
Frequently Asked Questions About ReiThera
Does ReiThera hold EMA or MHRA GMP certificates?
CDMO Signal tracks 4 EMA GMP certificates for ReiThera.
How many clinical programs is ReiThera linked to?
ReiThera is associated with 1 clinical trial in CDMO Signal's ClinicalTrials.gov-sourced data.
What is ReiThera's CDMO Signal Score?
ReiThera has a Signal Score of 71/100, based on quality, operations, financial stability, and capacity data.
Evaluating ReiThera for a manufacturing program?
Use the free AI matchmaker to compare ReiThera against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Thermo Fisher Scientific
Plainville, MA · Alachua, FL · Cambridge, MA
Signal Score: 81.0
AAV, Lentiviral, Plasmid DNA, Adenoviral, Plasmid
SK pharmteco
Dublin, Ireland. Rancho Cordova, CA. King of Prussia, PA. Houston, TX. Korea. France.
Signal Score: 79.5
Viral Vectors, AAV, Lentiviral, Adenoviral, HPAPIs, Small Molecules, Peptides, BioCatalysis, Chromatography, Cell Therapy
Exothera
Jumet, BE
Signal Score: 78.1
AAV, Adenoviral, Lentiviral
Advent Bioservices
London, United Kingdom
Signal Score: 78.1
AAV, Lentiviral, Adenoviral
Vigene Biosciences
Rockville, MD
Signal Score: 72.5
AAV, Lentiviral, Adenoviral